- Home
- AUID vs CURX Comparison
AUID vs CURX Comparison
Compare AUID & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUID
- CURX
- Stock Information
- Founded
- AUID 2009
- CURX 2018
- Country
- AUID United States
- CURX United States
- Employees
- AUID N/A
- CURX N/A
- Industry
- AUID Computer Software: Prepackaged Software
- CURX Biotechnology: Pharmaceutical Preparations
- Sector
- AUID Technology
- CURX Health Care
- Exchange
- AUID Nasdaq
- CURX Nasdaq
- Market Cap
- AUID 35.6M
- CURX 29.7M
- IPO Year
- AUID N/A
- CURX 2025
- Fundamental
- Price
- AUID $1.67
- CURX $0.52
- Analyst Decision
- AUID
- CURX
- Analyst Count
- AUID 0
- CURX 0
- Target Price
- AUID N/A
- CURX N/A
- AVG Volume (30 Days)
- AUID 87.5K
- CURX 2.7M
- Earning Date
- AUID 11-12-2025
- CURX 09-09-2025
- Dividend Yield
- AUID N/A
- CURX N/A
- EPS Growth
- AUID N/A
- CURX N/A
- EPS
- AUID N/A
- CURX N/A
- Revenue
- AUID $1,834,458.00
- CURX N/A
- Revenue This Year
- AUID N/A
- CURX N/A
- Revenue Next Year
- AUID N/A
- CURX N/A
- P/E Ratio
- AUID N/A
- CURX N/A
- Revenue Growth
- AUID 141.81
- CURX N/A
- 52 Week Low
- AUID $1.64
- CURX $3.61
- 52 Week High
- AUID $9.58
- CURX $8.60
- Technical
- Relative Strength Index (RSI)
- AUID 34.23
- CURX N/A
- Support Level
- AUID $1.64
- CURX N/A
- Resistance Level
- AUID $2.82
- CURX N/A
- Average True Range (ATR)
- AUID 0.33
- CURX 0.00
- MACD
- AUID -0.05
- CURX 0.00
- Stochastic Oscillator
- AUID 3.18
- CURX 0.00
About AUID authID Inc.
AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.
About CURX Curanex Pharmaceuticals Inc Common Stock
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.